J. Mark Nickell & Co’s HCA Healthcare HCA Stock Holding History

J. Mark Nickell & Co’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-500	Closed	-$237K	–	34
2026 Q1	$237K	Buy	+500	New	+$252K	0.21%	28

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

J. Mark Nickell & Co's HCA Position: Q2 2026 in Review

J. Mark Nickell & Co sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 500 shares — an estimated $237K sold.

J. Mark Nickell & Co first reported a position in HCA in Q1 2026 and held it in 1 quarter. The position peaked at $237K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

J. Mark Nickell & Co reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
J. Mark Nickell & Co sold 500 HCA Healthcare shares in Q2 2026, an estimated $237K.
J. Mark Nickell & Co first reported a position in HCA Healthcare in Q1 2026 and held it in 1 quarter.
J. Mark Nickell & Co's HCA Healthcare position peaked at $237K in Q1 2026.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on J. Mark Nickell & Co's 13F filing for Q2 2026, filed 11 Aug 2026.